(Q42949667)

English

Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors

scientific article published on September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Orazio Nicolotti

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Ilenia Giangreco

object named as

Ilenia Giangreco

3

0 references

Angela Stefanachi

object named as

Angela Stefanachi

6

0 references

Leonardo Pisani

object named as

Leonardo Pisani

1

0 references

Francesco Leonetti

object named as

Francesco Leonetti

4

0 references

object named as

Marco Catto

2

0 references

Saverio Cellamare

object named as

Saverio Cellamare

7

0 references

8

object named as

Angelo Carotti

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1616-1630

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Prevention of age-associated dementia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenomics and therapeutic strategies for dementia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease: strategies for disease modification

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Current and future therapy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine: a comprehensive review of safety and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative Abeta immunotherapy approaches for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

How to approach Alzheimer's disease therapy using stem cell technologies.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-amyloid treatments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug development for Alzheimer's disease: where are we now and where are we headed?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Can novel therapeutics halt the amyloid cascade?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational approach to discover multipotent anti-Alzheimer drugs.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Homodimeric tacrine congeners as acetylcholinesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of Huperzine A−Tacrine Hybrids as Potent Inhibitors of Human Cholinesterases Targeting Their Midgorge Recognition Sites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Fragments, network biology and designing multiple ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetylcholinesterase interaction with Alzheimer amyloid beta.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid-cholinesterase interactions. Implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-target-directed ligands to combat neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved protein-ligand docking using GOLD

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Scalable molecular dynamics with NAMD

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetylcholinesterase: mechanisms of covalent inhibition of wild-type and H447I mutant determined by computational analyses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Ueber die Verbindungen der Phenole mit Acetessigäther

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and photobiological activity of new methylpsoralen derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting Relative Binding Free Energies of Tacrine−Huperzine A Hybrids as Inhibitors of Acetylcholinesterase§

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000210

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.201000210

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42949667&oldid=1974322730"